Document is current
Any future updates will be listed below
-
Authors
Qiao, Longliang https://orcid.org/0000-0002-4480-1040
Niu, Lingxue
Wang, Zhihao
Deng, Zhenqiang
Di, Dai
Ma, Xiaoding
Zhou, Yang
Kong, Deqiang
Wang, Qilin
Yin, Jianli
Jin, Lingli
Sun, Jing
Feng, Bo
Lu, Weiqiang https://orcid.org/0000-0003-1349-6597
Cai, Fengfeng https://orcid.org/0000-0002-7390-1673
Guan, Ningzi https://orcid.org/0000-0001-6174-8053
Ye, Haifeng https://orcid.org/0000-0002-5482-8116
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (32250010, 32430064, 32261160373)
- License Information
-
More Information
Article History
Received: 18 December 2023
Accepted: 14 February 2025
First Online: 17 March 2025
Competing interests
: H.Y., L.N., L.Q., Z.W., and N.G. are listed as inventors on a Chinese patent application (number 202210607219.2: “A prokaryotic far-red light-regulated transcriptional activation system: construction method and application in tumor therapy”) submitted by ECNU, which covers the optogenetic NETMAP system. The other authors declare no competing interests.
